CDH1 and ovarian carcinoma: In the present study we observed coexpression of E-cadherin and N-cadherin in the TGF-β treated ovarian cancer cells without changes of morphological feature, slight decrease of occludin, and reduced transepithelial resistance all indicating dysfunctional tight junctions.